Skip to content

Calumet, Inc. CLMT Accrued Compensation

Accrued Compensation at other companies

Vaxcyte, Inc. logo
Vaxcyte, Inc.PCVX
-$15.02M-4.2%
Tetra Tech logo
Tetra TechTTEK
-$126.66M-24.6%
Corvex
 logo
Corvex MOVE
$364K+17.8%
Kimberly-Clark logo
Kimberly-ClarkKMB
$284M-27.9%
Samsara logo
SamsaraIOT
$59.58M+36.4%
Kenvue logo
KenvueKVUE
$345M-1.4%

Other financials

Income statement

See full
Revenue$1.0B+3.6%
Gross profit-$87.5M-7.5%
Operating income-$171.3M-252%
Net income-$317.0M-95.7%
EPS (diluted)-$3.64-94.7%

Balance sheet

See full
Cash & equivalents$138.6M+12.3%
Total debt$2.3B-9.0%
Total equity-$1.0B-21.0%
Total assets$2.8B-2.4%

Cash flow

See full
Operating cash flow-$86.2M-194%
CapEx$13.2M-25.0%
Free cash flow-$99.4M-112%

Valuation

See full
Market cap$2.86B+185%
Enterprise value$5.06B+50.3%
P/S0.7×+0.4×

Profitability

See full
Gross margin5.8%+4.1pp
Operating margin4.8%
Net margin-4.5%-1.4pp
FCF margin0.1%

Returns & leverage

See full
Return on equity19.8%
Debt / equity-2.2×
Current ratio-0.1×

Where this comes from

Reported directly by Calumet, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccruedSalaries.

The official record: Calumet, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Calumet, Inc.'s accrued compensation.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Calumet, Inc.'s accrued compensation?
Calumet, Inc. (CLMT) reported accrued compensation of -$19.5M in Q1 2026.
How has Calumet, Inc.'s accrued compensation changed year-over-year?
Calumet, Inc.'s accrued compensation decreased by 95.0% year-over-year, from -$10M to -$19.5M.
What is the long-term trend for Calumet, Inc.'s accrued compensation?
Over 2 years (2022 to 2024), Calumet, Inc.'s accrued compensation has grown at a -35.1% compound annual growth rate (CAGR), from $9.5M to $4M.